[Drug nephrotoxicity]
1Département de néphrologie, clinique internationale du Parc-Monceau, 21, rue de Chazelles, 75017 Paris, France.
Abstract:
Drug-induced nephrotoxicity (DIN) remains a current problem with economic and medical consequences. It affects all nephron segments. Recovery of renal function is based on the identification of risk factors, early diagnosis of renal disease, rapid (if possible) cessation of the causative agent and, in some cases, adjunctive therapy. Prevention is based on identification of early markers of DIN, correction of risk factors, initial assessment of renal function for adequate dosage adjustment and exclusion of other nephrotoxic factors. It has recently been proposed to standardize the phenotype of iatrogenic renal disease and, on the other hand, new markers of renal toxicity allowing early diagnosis and therefore better management of nephrotoxicity.
Insights
Drug-induced nephrotoxicity (DIN) is a significant health issue affecting kidney function. Early detection and intervention are crucial for managing and preventing kidney damage caused by medications.
Area of Science:
- Nephrology
- Pharmacology
- Toxicology
Background:
- Drug-induced nephrotoxicity (DIN) presents substantial medical and economic challenges.
- This condition impacts all segments of the nephron, leading to impaired renal function.
- Effective management relies on identifying risk factors and early diagnosis.
Purpose of the Study:
- To highlight the importance of early diagnosis and intervention in managing drug-induced nephrotoxicity.
- To discuss strategies for preventing kidney damage from medications.
- To introduce novel approaches for identifying and managing iatrogenic renal disease.
Main Methods:
- Review of current understanding of drug-induced nephrotoxicity.
- Analysis of established and emerging diagnostic and therapeutic strategies.
- Discussion of proposed standardization of iatrogenic renal disease phenotypes.
Main Results:
- Recovery of renal function depends on prompt identification of causative agents and risk factors.
- Prevention strategies include early marker identification and renal function assessment for dosage adjustment.
- New markers for early diagnosis are being developed to improve patient outcomes.
Conclusions:
- Standardizing the phenotype of iatrogenic renal disease is proposed.
- Development of new renal toxicity markers facilitates earlier diagnosis and better management.
- A comprehensive approach involving risk factor identification, early diagnosis, and timely intervention is key to combating DIN.
Related Concept Videos
Drug toxicity: Drug–Drug Interaction
Pharmacokinetics: Drug–Drug Interactions
Bioequivalence of Drugs: Drugs with Multiple Indications
FDA Approved Drugs: Changes to Approved Drugs
Tissue-Drug Binding: Localization of Drugs and its Significance
Drugs can bind to different tissue components, enhancing their distribution and localization. The factors influencing drug localization in tissues include the drug's lipophilicity, structural characteristics, tissue perfusion rate, and pH differences. These factors determine...
Factors Affecting Protein-Drug Binding: Drug Interactions
Displacement interactions can have varying outcomes, ranging from toxicity to virtually...


